JP2008515793A5 - - Google Patents

Download PDF

Info

Publication number
JP2008515793A5
JP2008515793A5 JP2007534071A JP2007534071A JP2008515793A5 JP 2008515793 A5 JP2008515793 A5 JP 2008515793A5 JP 2007534071 A JP2007534071 A JP 2007534071A JP 2007534071 A JP2007534071 A JP 2007534071A JP 2008515793 A5 JP2008515793 A5 JP 2008515793A5
Authority
JP
Japan
Prior art keywords
labeled
compound
protected
fdg
alkanoate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007534071A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008515793A (ja
JP5000521B2 (ja
Filing date
Publication date
Priority claimed from GBGB0422004.2A external-priority patent/GB0422004D0/en
Application filed filed Critical
Publication of JP2008515793A publication Critical patent/JP2008515793A/ja
Publication of JP2008515793A5 publication Critical patent/JP2008515793A5/ja
Application granted granted Critical
Publication of JP5000521B2 publication Critical patent/JP5000521B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007534071A 2004-10-05 2005-09-23 脱保護の方法 Expired - Fee Related JP5000521B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0422004.2 2004-10-05
GBGB0422004.2A GB0422004D0 (en) 2004-10-05 2004-10-05 Method of deprotection
PCT/GB2005/003692 WO2006037950A1 (en) 2004-10-05 2005-09-23 Method of deprotection

Publications (3)

Publication Number Publication Date
JP2008515793A JP2008515793A (ja) 2008-05-15
JP2008515793A5 true JP2008515793A5 (enExample) 2008-11-06
JP5000521B2 JP5000521B2 (ja) 2012-08-15

Family

ID=33428035

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007534071A Expired - Fee Related JP5000521B2 (ja) 2004-10-05 2005-09-23 脱保護の方法

Country Status (6)

Country Link
US (1) US7714115B2 (enExample)
EP (1) EP1797029A1 (enExample)
JP (1) JP5000521B2 (enExample)
CN (1) CN101035755B (enExample)
GB (1) GB0422004D0 (enExample)
WO (1) WO2006037950A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070260267A1 (en) * 2002-10-07 2007-11-08 Nicoson Zachary R Localizing obturator
KR101497406B1 (ko) * 2006-12-21 2015-03-02 니혼 메디피직스 가부시키가이샤 방사성 화상 진단제
EP2128130B1 (en) 2006-12-27 2018-10-10 Nihon Medi-Physics Co., Ltd. Process for production of precursor compound for radioactive halogen-labeled organic compound
JP5258583B2 (ja) * 2007-02-13 2013-08-07 日本メジフィジックス株式会社 放射性画像診断剤の製造方法
EP2005970A1 (de) 2007-06-22 2008-12-24 Berlin Science Partners GmbH i.V. Bildgebende Diagnostik durch Kombination von Kontrastmitteln
US8043316B2 (en) 2008-05-02 2011-10-25 Suros Surgical Systems, Inc. Adjustable spacer
GB0905515D0 (en) * 2009-03-31 2009-05-13 Ge Healthcare Ltd Radiolabelling methods
CA2780930A1 (en) * 2009-11-17 2011-05-26 Mathias Berndt Method for production of f-18 labeled glutamic acid derivatives
WO2011157443A1 (en) * 2010-06-17 2011-12-22 N.V. Organon (11b,17a)-11-(4-(2-11c-acetyl)phenyl)-17,23-epoxy-19,24-dinorchola-4,9,20-trien-3-one
EP2793954B1 (en) * 2011-12-21 2020-10-21 GE Healthcare Limited 18f-fluciclovine compositions in citrate buffers
AU2011351550B2 (en) * 2010-12-29 2017-02-02 Ge Healthcare Limited Eluent solution
US9101895B2 (en) 2011-04-15 2015-08-11 General Electric Company System for mixing and dispersing microbubble pharmaceuticals
KR101221483B1 (ko) * 2011-05-13 2013-01-16 서강대학교산학협력단 Ｆ-18 표지 방사성의약품 합성 장치 및 방법
US11534494B2 (en) 2011-12-21 2022-12-27 Ge Healthcare Limited Formulation and method of synthesis
GB201411569D0 (en) 2014-06-30 2014-08-13 Ge Healthcare Ltd Novel formulation and method of synthesis
JP2017528509A (ja) * 2014-06-06 2017-09-28 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 自己遮蔽ベンチトップ型ケミストリシステム
EP4497477A3 (en) * 2016-06-10 2025-04-02 The Johns Hopkins University Improved synthesis of the radiolabeled prostate-specific membrane antigen (psma) inhibitor [18f]dcfpyl
WO2018104900A1 (en) * 2016-12-07 2018-06-14 Università Degli Studi Di Bari Aldo Moro Stable f-dopa formulations and uses thereof
US11318216B2 (en) * 2017-06-23 2022-05-03 Nihon Medi-Physics Co., Ltd. Method for producing radiohalogen-labeled compound and method for producing radiopharmaceutical
WO2022196734A1 (ja) * 2021-03-17 2022-09-22 Tdk株式会社 含フッ素化合物および造影剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5135683A (en) 1991-03-28 1992-08-04 Arco Chemical Technology, L.P. Process for producing a deprotected alkoxylated polyol
US5393908A (en) 1992-06-25 1995-02-28 Satyamurthy; Nagichettiar Synthesis of N-formyl-3,4-di-t-butoxycarbonyloxy-6-(trimethylstannyl)-L-phenylalanine ethyl ester and its regioselective radiofluorodestannylation to 6-[18 F]fluoro-L-dopa
DE4330889C2 (de) * 1993-09-11 2002-10-31 Emtec Magnetics Gmbh Verfahren zur Wiedergewinnung von Rohmaterialien aus magnetischen Aufzeichnungsträgern
US5922810A (en) 1995-07-31 1999-07-13 Fmc Corporation Deprotection of protected functional polymers
BE1010280A3 (fr) 1996-05-02 1998-05-05 Coincidence S A Procede et dispositif de synthese de 2-[18f] fluoro-2-deoxy-d-glucose.
DE10104250A1 (de) 2001-01-31 2002-08-14 Deutsches Krebsforsch Markierungsfähige Verbindungen zur einfachen Synthese von 3'-[18F]Fluor-3'-deoxythymidin und Verfahren zu deren Herstellung
EP1356827A1 (en) * 2002-04-24 2003-10-29 Mallinckrodt Inc. Method for obtaining a 2-18F-fluor-2-deoxy-D-glucose (18F-FDG)-solution
US7022872B2 (en) 2003-12-19 2006-04-04 Molecular Technologies, Inc. Method for making fluorine labeled L-Dopa

Similar Documents

Publication Publication Date Title
JP2008515793A5 (enExample)
CN101094824B (zh) 在醇溶剂中制备有机氟化物的方法
SK76898A3 (en) Method for the synthesis of benzimidazole compounds
JP2008528445A5 (enExample)
JP2009527517A5 (enExample)
JPWO2008102615A1 (ja) β−アルコキシプロピオンアミド類の製造方法
JP2008515793A (ja) 脱保護の方法
HRP20191589T1 (hr) Postupci za pripravu derivata galnac kiseline
AR076969A1 (es) Un procedimiento para la preparacion de febuxostat
JP2013517320A5 (enExample)
JP2008540414A5 (enExample)
KR20180091672A (ko) 디뉴클레오사이드 폴리포스페이트 화합물의 제조방법
WO2002051781A1 (fr) Procede permettant de preparer un compose d'halohydrine optiquement actif
JP4629322B2 (ja) シロスタゾールの製造法
ES2751698T3 (es) Procedimiento para la preparación del éster etílico del ácido 1-(2-halogen-etil)-4-piperidina-carboxílico
JP2008540628A5 (enExample)
US8076499B2 (en) Method for preparing precursor of radioactive 3-iodobenzylguanidine
CA2671816A1 (en) Salts of imidazole-5-carboxylic acid derivatives, a method for preparing same and pharmaceutical compositions comprising same
US11332489B2 (en) Process for preparing imetelstat
EP1851212B1 (en) New process for synthesis of proton pump inhibitors
US10144703B2 (en) Process for the preparation of Verapamil hydrochloride
CN104540818A (zh) 环烷醇衍生物制备方法及唑衍生物制备方法
AU2015242231B2 (en) A process for preparation of Levothyroxine and salts thereof
BRPI0616169B8 (pt) cloridrato de lercanidipina na forma polimorfa v, composição farmacêutica compreendendo dito composto e processos para preparação de cloridrato de lercanidipina
JP6018578B2 (ja) Ｐｅｔ前駆体の製造